Denali Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-2,606
Closed -$228K – 328
2025
Q4
$228K Buy
+2,606
New +$198K 0.03% 305
2021
Q2
– Sell
-200
Closed -$12K – 305
2021
Q1
$12K Sell
200
-9,700
-98% -$614K ﹤0.01% 307
2020
Q4
$646K Hold
9,900
– – 0.11% 186
2020
Q3
$490K Buy
+9,900
New +$511K 0.1% 198

Other funds holding GMED

Denali Advisors's GMED Position: Q1 2026 in Review

Denali Advisors sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 2,606 shares — an estimated $228K sold.

Denali Advisors first reported a position in GMED in Q3 2020 and held it in 4 quarters. The position peaked at $646K in Q4 2020. 610 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Denali Advisors reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • Denali Advisors sold 2,606 Globus Medical shares in Q1 2026, an estimated $228K.
  • Denali Advisors first reported a position in Globus Medical in Q3 2020 and held it in 4 quarters.
  • Denali Advisors's Globus Medical position peaked at $646K in Q4 2020.
  • 610 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Denali Advisors's 13F filing for Q1 2026, filed 8 May 2026.